Specifically, HLA-DR3 is associated with Graves’ disease in humans; the frequency of DR3 in Graves’ disease patients was 40–55 % compared to 15–30 % in the general population, resulting in a relative risk for people with HLA-DR3 of 3.4 [12]. This evidence concerns the gene TNFRSF25 and Graves disease.